ReachMD
Be part of the knowledge.™Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?
Post-Marketing Drug Surveillance
Share this program on:
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Presenters
Comments
Overview
How much did regular use of Vioxx for long periods of time increase the risk of heart attack? What is the risk of suicide with the SSRI’s in select patient populations? The answers can only come through a robust system for monitoring post-marketing drug safety. Yet the new regulations being considered by the FDA and Congress may not be a prescription for improved safety.
Presenters
Recommended
Details
Presenters
Comments
Recommended
Overview
How much did regular use of Vioxx for long periods of time increase the risk of heart attack? What is the risk of suicide with the SSRI’s in select patient populations? The answers can only come through a robust system for monitoring post-marketing drug safety. Yet the new regulations being considered by the FDA and Congress may not be a prescription for improved safety.
Presenters
Facebook Comments